Cambridge-led natural history study identifies MTRFR/C12orf65 deficiency to improve diagnosis and therapy development
This research will potentially show a method that may be quicker and better at identifying baseline disease phenotypes to support research and clinical trials. NEW YORK, NEW YORK, UNITED STATES, April 14, 2023 /EINPresswire.com/ -- Cambridge-led …